Method for the treatment of a ubiquitin conjugating disorder
US8003572B2 · kind B2 · utility
0Cited by
4References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 28, 2006 |
| Grant date | Aug 23, 2011 |
| Priority date | — |
| Expiry date | Oct 26, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5383
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for identifying compounds that selectively bind one or more active sites within an ubiquitin conjugating enzyme. The compounds identified by the methods are useful in the treatment of disorders attributed to dysregulated ubiquitin conjugating enzyme function, specifically in hyperproliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.